A large prospective cohort study of 90 BC patients with first recurrence/metastatic disease and preliminary results from a prospective study in 10 ER+ MBC patients showed an excellent inter-observer agreement for [18F]-FES uptake (0.90 and 0.98, respectively) [22••, 78]. The gene discussed is ESR1; the disease is breast cancer.